[gpfsug-discuss] EXTERNAL: Potential talks for GPFS UG May 20th

[McLaughlin, Sandra M]

Life Sciences talk would be spot on for me too, please.

Sandra McLaughlin

From: gpfsug-discuss-bounces at gpfsug.org [mailto:gpfsug-discuss-bounces at gpfsug.org] On Behalf Of Mark.Roberts at awe.co.uk
Sent: 26 March 2015 15:24
To: gpfsug-discuss at gpfsug.org
Subject: Re: [gpfsug-discuss] EXTERNAL: Potential talks for GPFS UG May 20th

As well as supporting the efforts of our friends at NERSC I think should be a good interesting talk.

Mark Roberts

________________________________
From: gpfsug-discuss-bounces at gpfsug.org<mailto:gpfsug-discuss-bounces at gpfsug.org> [mailto:gpfsug-discuss-bounces at gpfsug.org] On Behalf Of Ross Keeping3
Sent: 26 March 2015 15:00
To: gpfsug-discuss at gpfsug.org<mailto:gpfsug-discuss at gpfsug.org>
Subject: EXTERNAL: [gpfsug-discuss] Potential talks for GPFS UG May 20th

Hi

There are a couple of talks we could include in the one day GPFS UG on May 20th.

We'd appreciate some feedback on whether there is any interest or objection to including these.

These are:
1) Tivoli Storage Productivity Center Technical Demo: A tool for managing heterogeneous storage infrastructures and specifically GPFS. Can read more here http://www-03.ibm.com/software/products/en/tivostorprodcent

2) GPFS for life sciences: A member of NERSC would like to talk about their efforts to improve GPFS file systems for a life sciences workload - specifically genomic sequencing and analysis that ensues. Details about life science workflow and requirements will be provided so the listener may understand the aspects of GPFS that are important.

Cheers,
Ross
Unless stated otherwise above:
IBM United Kingdom Limited - Registered in England and Wales with number 741598.
Registered office: PO Box 41, North Harbour, Portsmouth, Hampshire PO6 3AU

___________________________________________________ ____________________________ The information in this email and in any attachment(s) is commercial in confidence. If you are not the named addressee(s) or if you receive this email in error then any distribution, copying or use of this communication or the information in it is strictly prohibited. Please notify us immediately by email at admin.internet(at)awe.co.uk, and then delete this message from your computer. While attachments are virus checked, AWE plc does not accept any liability in respect of any virus which is not detected. AWE Plc Registered in England and Wales Registration No 02763902 AWE, Aldermaston, Reading, RG7 4PR

________________________________

AstraZeneca UK Limited is a company incorporated in England and Wales with registered number: 03674842 and a registered office at 2 Kingdom Street, London, W2 6BD.

Confidentiality Notice: This message is private and may contain confidential, proprietary and legally privileged information. If you have received this message in error, please notify us and remove it from your system and note that you must not copy, distribute or take any action in reliance on it. Any unauthorised use or disclosure of the contents of this message is not permitted and may be unlawful.

Disclaimer: Email messages may be subject to delays, interception, non-delivery and unauthorised alterations. Therefore, information expressed in this message is not given or endorsed by AstraZeneca UK Limited unless otherwise notified by an authorised representative independent of this message. No contractual relationship is created by this message by any person unless specifically indicated by agreement in writing other than email.

Monitoring: AstraZeneca UK Limited may monitor email traffic data and content for the purposes of the prevention and detection of crime, ensuring the security of our computer systems and checking compliance with our Code of Conduct and policies.
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://gpfsug.org/pipermail/gpfsug-discuss_gpfsug.org/attachments/20150326/d3dc91f7/attachment-0003.htm>